COVENTRY STUDY FINDS LAPETUS LIFE EXPECTANCIES ARE SHORTER THAN COMPETITORS IN 85% OF CASES REVIEWED
After reviewing thousands of Lapetus life expectancy estimates, Coventry found that they are shorter than other leading life expectancy providers 85% of the time when comparing the same individuals. This suggests that their use of a general population base mortality table (rather than an insured population base mortality table) for life settlement underwriting contributes to their significantly shorter life expectancy estimates. A general population table is typically not used for these valuations because insured individuals over 65—those underwritten in any life settlement transaction—have average life expectancies more than three years longer than the general population. Study details are available at: coventry.com/research.
Coventry believes the impact on investors could be substantial and highly consequential. The insured's life expectancy is the single most important factor when determining the value of a life settlement.
When inaccurately short life expectancies cause such assets to be overvalued, it sets the stage for liquidity issues and potential investor losses. Indeed, there are numerous examples of significant life settlement losses arising from faulty life expectancies.
"It is essential for the integrity of the market and the welfare of investors that life expectancy providers use best practices and issue reliable estimates," said Alan Buerger, Coventry's Executive Chairman. "As a licensed life settlement provider, we are committed to upholding industry regulations and guidelines to maintain credibility and protect stakeholders."
Coventry is the leader and creator of the secondary market for life insurance. For more than 25 years, we have been driving the industry forward and expanding opportunities for life insurance policyowners. Coventry's deep experience combined with a fierce commitment to consumer rights makes Coventry the clear market leader, a position we use to raise industry standards and expand consumer choice. To date, we have delivered more than
View original content:https://www.prnewswire.com/news-releases/coventry-study-finds-lapetus-life-expectancies-are-shorter-than-competitors-in-85-of-cases-reviewed-302140316.html
SOURCE Coventry



The future of behavioral healthcare for farmers
NICB Works With Kentucky Lawmakers to Protect Consumers from Auto Glass Fraud
Advisor News
- The modern advisor: Merging income, insurance, and investments
- Financial shocks, caregiving gaps and inflation pressures persist
- Americans unprepared for increased longevity
- More investors will seek comprehensive financial planning
- Midlife planning for women: why it matters and how advisors should adapt
More Advisor NewsAnnuity News
- LIMRA: Annuity sales notch 10th consecutive $100B+ quarter
- AIG to sell remaining shares in Corebridge Financial
- Corebridge Financial, Equitable Holdings post Q1 earnings as merger looms
- AM Best Assigns Credit Ratings to Calix Re Limited
- Transamerica introduces new RILA with optional income features
More Annuity NewsHealth/Employee Benefits News
- City OKs 2025-28 contract for Racine Fire Staff Officers' union
- Rob Schofield: NC’s new Medicaid ‘compromise’ comes at a cost
- Prime Healthcare hospitals will stay in-network with Blue Cross and Blue Shield of Illinois, after months of uncertainty
- LEADING HEALTH ORGANIZATIONS URGE NC LAWMAKERS TO RECONSIDER IMPLEMENTATION OF MEDICAID CUTS
- PCA PAPER WORKERS IN MINNESOTA RATIFY STRONG AGREEMENT WITH MAJOR WAGE GAINS, PROTECTED HEALTH INSURANCE
More Health/Employee Benefits NewsLife Insurance News
- AM Best Assigns Credit Ratings to Tokio Marine Newa Insurance Co., Ltd.
- Earnings roundup: Prudential works to save ‘unique’ Japanese market
- How life insurance became a living-benefits strategy
- Financial Focus : Keep your beneficiary choices up to date
- Equitable-Corebridge merger casts shadow over life insurance earnings
More Life Insurance News